LAC MED (KLSE:LACMED) unit LAC Medical Supplies secured a letter of award worth 78.9 million ringgit for the supply and delivery of chemical pathology reagents to 10 Health Ministry hospitals in Kedah, Malaysia.
The four-year contract covers an "instrument placement" arrangement for reagents and related testing materials, with deliveries based on actual hospital usage, according to a Tuesday Malaysian bourse filing.
The agreement runs from June 15, 2026, to June 14, 2030, and is expected to contribute positively to company earnings.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments